Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Non-Current Deffered Revenue of $13.46 million for Q2 2026, up 52.4% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
At the end of FY2016, Biocryst Pharmaceuticals' Non-Current Deffered Revenue came in at $8.18 million, down 15.4% from FY2015.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of 2.9% (FY2011 to FY2016).
- In prior years, Biocryst Pharmaceuticals' Non-Current Deffered Revenue was $9.67 million in FY2015 (+172.4%), $3.55 million in FY2014 (-25.0%), $4.74 million in FY2013 (-20.0%) and $5.92 million in FY2012 (-16.7%).
- The Q2 2026 figure stands as the highest quarterly Non-Current Deffered Revenue since Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | 13.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.46 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Sep 30, 2017 | 296,000.00 |
| Jun 30, 2017 | 7.59 Mn |
| Mar 31, 2017 | 7.89 Mn |
| Dec 31, 2016 | 8.18 Mn |
| Sep 30, 2016 | 8.48 Mn |
| Jun 30, 2016 | 8.78 Mn |
| Mar 31, 2016 | 9.19 Mn |
| Dec 31, 2015 | 9.67 Mn |
| Sep 30, 2015 | 10.12 Mn |
| Jun 30, 2015 | 9.96 Mn |
| Mar 31, 2015 | 3.26 Mn |
| Dec 31, 2014 | 3.55 Mn |
| Sep 30, 2014 | 3.85 Mn |
| Jun 30, 2014 | 4.14 Mn |
| Mar 31, 2014 | 4.44 Mn |
| Dec 31, 2013 | 4.74 Mn |
| Sep 30, 2013 | 5.03 Mn |
| Jun 30, 2013 | 5.33 Mn |
API Access
Biocryst Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();